$100 Billion Here, $100 Billion There in Hep C Care

Costs and effectiveness of new treatments for hepatitis C

Mark Roberts, MD, MPP, provides an overview of hepatitis C and the new direct acting antivirals to target it. He explores cost effectiveness for these therapies and their likely impact on the hepatitis C epidemic.

These videos first appeared on BroadcastMed. BroadcastMed has provided video and digital content for 20 years to engage, educate, and inspire physicians and other healthcare providers.

MedPageToday is a trusted and reliable source for clinical and policy coverage that directly affects the lives and practices of health care professionals.

Physicians and other healthcare professionals may also receive Continuing Medical Education (CME) and Continuing Education (CE) credits at no cost for participating in MedPage Today-hosted educational activities.